Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Immunovant Initiates Dosing in ASCEND-GO 1, Phase 2a Trial of IMVT-1401

americanpharmaceuticalreviewMay 24, 2019

Tag: Immunovant Initiates , IMVT-1401 , ASCEND-GO 1

PharmaSources Customer Service